Application 083082
- Type
- ANDA
- Sponsor
- HIKMA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | TABLET;ORAL | 250MG | No | No |
| 002 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A083082-001 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | ||
| A083082-002 | CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 1999-09-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A083082-001 | CHLOROQUINE PHOSPHATE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A083082-002 | CHLOROQUINE PHOSPHATE | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 1999-09-17 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A083082-001 | CHLOROQUINE PHOSPHATE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A083082-002 | CHLOROQUINE PHOSPHATE | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 1999-09-17 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A083082-001 | CHLOROQUINE PHOSPHATE | 250MG | TABLET / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A083082-002 | CHLOROQUINE PHOSPHATE | 500MG | TABLET / ORAL | 1999-09-17 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A083082-001 | CHLOROQUINE PHOSPHATE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | Approved before 1982 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A083082-002 | CHLOROQUINE PHOSPHATE | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 1999-09-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A083082-001 | AA | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A083082-002 | AA | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A083082-001 | AA | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A083082-002 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A083082-001 | AA | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A083082-002 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A083082-001 | AA | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A083082-002 | AA | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Chloroquine Phosphate | CHLOROQUINE PHOSPHATE | Rising Pharma Holdings, Inc. | ee944d28-f596-4163-a502-e779c0d622bc | 2026-07-02 | Warnings, Adverse reactions | Chloroquine Phosphate CHLOROQUINE PHOSPHATE |
| Chloroquine Phosphate | CHLOROQUINE PHOSPHATE | Rising Pharma Holdings, Inc. | 06c69e2b-211b-4746-9f3a-f86d36520570 | 2026-07-02 | Warnings, Adverse reactions | Chloroquine Phosphate CHLOROQUINE PHOSPHATE |
| Chloroquine Phosphate | CHLOROQUINE PHOSPHATE | AvKARE | 0a342f72-45f9-3e12-e063-6394a90ae33e | 2026-01-13 | Warnings, Adverse reactions | Chloroquine Phosphate CHLOROQUINE PHOSPHATE |
| CHLOROQUINE PHOSPHATE | CHLOROQUINE PHOSPHATE | Chartwell RX, LLC | ff199f31-bfda-45f8-adbd-4662f7054f1c | 2025-12-10 | Warnings, Adverse reactions | CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-1195 | Chloroquine | Chloroquine Phosphate | West-ward Pharmaceutical Corp | ANDA | Current |
| 0143-2125 | Chloroquine | Chloroquine Phosphate | West-ward Pharmaceutical Corp | ANDA | Current |
| 55289-856 | Chloroquine | Chloroquine Phosphate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 68151-0487 | Chloroquine | Chloroquine Phosphate | Carilion Materials Management | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 39571 | SUPPL | 2009-11-16 |